Stock VTGN VISTAGEN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Vistagen Therapeutics, Inc.

Equities

VTGN

US92840H4002

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
4.48 USD +0.67% Intraday chart for Vistagen Therapeutics, Inc. +1.59% -12.84%
Apr. 25 Vistagen Announces Positive Results from Phase 2A Pilot Study of Ph15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue CI
Apr. 01 Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2 CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
VISTAGEN THERAPEUTICS, INC.
Bio Therapeutic Drugs
+1.57%+2.49%-12.06%+12.61%-73.09% 120M
Bearish
Bullish
Neutral
  1. Stock Market
  2. Equities
  3. VTGN Stock
  4. Charts Vistagen Therapeutics, Inc.
  5. Relative Strength Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW